Pink Sheet is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Pfizer Sells Nutrition Portfolio To Nestle For Nearly $12B

This article was originally published in The Pink Sheet Daily

Executive Summary

Pfizer’s price of $11.85 billion for selling its pediatric nutritionals business to Nestle came in at the upper end of what most analysts expected. It plans to use the cash it expects to receive – nearly $9 billion – mostly for share repurchases and ‘”tuck-in” M&A.

Advertisement

Related Content

What Does Pfizer’s Read Have To Say About It? A Lot, Actually
Pfizer Reorganizes Internally As It Moves Closer To Decision On Splitting Business
Pfizer Reorganizes Internally As It Moves Closer To Decision On Splitting Business
Pfizer Reorganizes Internally As It Moves Closer To Decision On Splitting Business
The Post-Patent Cliff Tab: Pharma Battered But Still Financially Strong, Says Moody’s
Ahead Of Schedule, Pfizer Prepares To Set Zoetis Free In Stock Swap
Pfizer Draws Curtain On Anti-infective Research; Refocuses On Next-gen Vaccines
Capsugel CEO Driesen Plots Post-Pfizer Course
Pfizer Will Unload Nutrition Division, Keep Consumer Product Unit
Reading Into Pfizer's Changes: First Steps For New CEO

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

PS074056

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel